Longitudinal BCVA Analysis of Low- or High -Dose MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase 2b/3 Randomized, Sham Controlled, Patient- and Assessor Masked Clinical Trial (RESTORE)
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要